Page last updated: 2024-10-31

nafamostat and Adenocarcinoma

nafamostat has been researched along with Adenocarcinoma in 3 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Adenocarcinoma: A malignant epithelial tumor with a glandular organization.

Research Excerpts

ExcerptRelevanceReference
" Nafamostat mesilate (FUT-175), a synthetic serine protease inhibitor, inhibited liver metastasis in a CDF1 mice model with colon 26 adenocarcinoma cells."3.68Inhibitory effect of nafamostat mesilate on metastasis into the livers of mice and on invasion of the extracellular matrix by cancer cells. ( Fuchimoto, S; Hizuta, A; Iwagaki, H; Kimura, T; Orita, K, 1992)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Homma, S1
Hayashi, K1
Yoshida, K1
Sagawa, Y1
Kamata, Y1
Ito, M1
Uwagawa, T1
Li, Z1
Chang, Z1
Xia, Q1
Peng, B1
Sclabas, GM1
Ishiyama, S1
Hung, MC1
Evans, DB1
Abbruzzese, JL1
Chiao, PJ1
Kimura, T1
Fuchimoto, S1
Iwagaki, H1
Hizuta, A1
Orita, K1

Other Studies

3 other studies available for nafamostat and Adenocarcinoma

ArticleYear
Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
    International immunopharmacology, 2018, Volume: 54

    Topics: Adenocarcinoma; B7-H1 Antigen; Benzamidines; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line,

2018
Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
    Cancer, 2007, May-15, Volume: 109, Issue:10

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Benzamidines; Caspase 8; Cell Line, Tumor; Enzyme

2007
Inhibitory effect of nafamostat mesilate on metastasis into the livers of mice and on invasion of the extracellular matrix by cancer cells.
    The Journal of international medical research, 1992, Volume: 20, Issue:4

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antithrombins; Benzamidines; Colonic Neoplasms; Extr

1992